BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sánchez-Valledor LF, Habermann TM, Murrieta-Alvarez I, Córdova-Ramírez AC, Rivera-Álvarez M, León-Peña A, Cantero-Fortiz Y, Olivares-Gazca JC, Ruiz-Delgado GJ, Ruiz-Argüelles GJ. Long-term results of the treatment of Hodgkin’s lymphoma in a resource-constrained setting: Real-world data from a single center. World J Clin Oncol 2021; 12(9): 800-807 [PMID: 34631443 DOI: 10.5306/wjco.v12.i9.800]
URL: https://www.wjgnet.com/2218-4333/full/v12/i9/800.htm
Number Citing Articles
1
Burhan Ferhanoglu, Tae Min Kim, Amado Karduss, David Brittain, Gayane Tumyan, Mubarak Al-mansour, Marta Zerga, Yuqin Song, Silvia Rivas-Vera, Yok Lam Kwong, Soon Thye Lim, Su-Peng Yeh, Arif Abdillah, Zhongwen Huang, Mehul Dalal, Hui Wan, Mark Hertzberg. Treatment pathways and clinical outcomes in Hodgkin lymphoma outside Europe and North America: results from the international, multicenter, retrospective, B-HOLISTIC studyLeukemia & Lymphoma 2022; 63(14): 3317 doi: 10.1080/10428194.2022.2126281
2
José A. Fernández-Gutiérrez, Oscar A. Reyes-Cisneros, Mark R. Litzow, Lorena Bojalil-Álvarez, Elizabeth García-Villaseñor, Eliezer Tomas Gómez-Gomez, Iván Murrieta-Álvarez, David Gomez-Almaguer, Cesar H. Gutierrez-Aguirre, Amado J. Karduss-Urueta, Guillermo J. Ruiz-Delgado, Guillermo José Ruiz-Argüelles. High dose melphalan is an adequate preparative regimen for autologous hematopoietic stem cell transplantation in relapsed/refractory lymphomaHematology 2022; 27(1): 449 doi: 10.1080/16078454.2022.2059630
3
Dinesh Bhurani, Reena Nair, Senthil Rajappa, Suparna Ajit Rao, Nithya Sridharan, Rakesh Reddy Boya, Ganapathi S. Raman, Hari Menon, Arun Seshachalam, Ramesh Nimmagadda. Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From IndiaFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.799948